Global Tissue Plasminogen Activator Market: Regional Analysis
North America is the leader in the global tissue plasminogen activator market, owing to rising
awareness about stroke and huge spending on treatment of stroke. For instance, in 2017, the
American Heart Association (AHA) recorded stroke costs as US$ 34 billion in the U.S. every
year, which includes medicines for the treatment of stroke and cost of health care services.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2469
Asia pacific is the fastest growing region in the tissue plasminogen activator market, owing to
increasing demand drug coupled with rising stroke incidences in the region. According to WHO,
Indonesia, Philippines, China, and India have highest rates of stroke, which is 186.3, 134.7,
128, and 71.5, respectively, as recorded in 2017.
Global Tissue Plasminogen Activator Market: Competitive Landscape
Key players operating in the global tissue plasminogen activator market include Bayer AG,
Abcam, Calbiochem, Merck & Company, Roche, Sekisui Diagnostics, Genentech, Sigma-Aldrich,
Taj Pharmaceuticals, and Cadila Healthcare Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702